Published in
American Association for the Advancement of Science, Science Translational Medicine, 602(13), 2021
DOI: 10.1126/scitranslmed.abd4816
Links
Tools
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models
Journal article published in 2021 by
Limeng Wu 
,
Sasa Vasilijic ,
Yao Sun ,
Jie Chen ,
Lukas D. Landegger ,
Yanling Zhang,
Wenjianlong Zhou,
Jun Ren ,
Samuel Early,
Zhenzhen Yin ,
William W. Ho ,
Na Zhang ,
Xing Gao ,
Grace Y. Lee ,
Meenal Datta
and other authors.
,
Sasa Vasilijic ,
Yao Sun ,
Jie Chen ,
Lukas D. Landegger ,
Yanling Zhang,
Wenjianlong Zhou,
Jun Ren ,
Samuel Early,
Zhenzhen Yin ,
William W. Ho ,
Na Zhang ,
Xing Gao ,
Grace Y. Lee ,
Meenal Datta
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Normalizing the tumor microenvironment with losartan prevents tumor-induced hearing loss and enhances radiation response in schwannoma rodent models.